dc.creatorYu, Hanxiao
dc.creatorYang, He
dc.creatorShi, Enxue
dc.creatorTang, Wenjun
dc.date.accessioned2020-08-25T17:06:24Z
dc.date.accessioned2022-09-23T18:01:46Z
dc.date.available2020-08-25T17:06:24Z
dc.date.available2022-09-23T18:01:46Z
dc.date.created2020-08-25T17:06:24Z
dc.identifier2590-0986
dc.identifierhttps://doi.org/10.1016/j.medidd.2020.100063
dc.identifierhttp://hdl.handle.net/20.500.12010/12223
dc.identifierhttps://doi.org/10.1016/j.medidd.2020.100063
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3493429
dc.description.abstractPhosphorus-containing drugs belong to an important class of therapeutic agents and are widely applied in daily clinical practices. Structurally, the phosphorus-containing drugs can be classified into phosphotriesters, phosphonates, phosphinates, phosphine oxides, phosphoric amides, bisphosphonates, phosphoric anhydrides, and others; functionally, they are often designed as prodrugs with improved selectivity and bioavailability, reduced side effects and toxicity, or biomolecule analogues with endogenous materials and antagonistic endoenzyme supplements. This review summarized the phosphorus-containing drugs currently on the market as well as a few promising molecules at clinical studies, with particular emphasis on their structural features, biological mechanism, and indications.
dc.languageeng
dc.publisherMedicine in Drug Discovery
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectPhosphorus-containing drugs
dc.subjectProdrugs
dc.subjectDrug modification
dc.subjectPhosphite, phosphate
dc.titleDevelopment and clinical application of phosphorus-containing drugs


Este ítem pertenece a la siguiente institución